| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
incidence, risk factors, and prognostic significance of extramedullary
involvement (EMI) in adult patients with acute myeloid leukemia (AML)
have not been established yet. This study analyzed clinical and
biological characteristics, the impact on prognosis, and the cumulative
incidence of EMI in a monocentric retrospective series. All adult
patients diagnosed with AML observed in our institution between January
2010 and December 2017 were included in the analysis.
Materials and Methods
1. Baseline characteristics of the study population.
|Figure 1. Sites of extramedullary involvement for treatment phase of acute myeloid leukemia.
|Table 2. Citofluorimetry markers of the study population.
|Figure 2. Overall survival of 27 EMI patients who received treatment.
|Figure 3. Overall survival according allo-HSCT.